PGRMC1 and early-onset autosomal dominant Alzheimer disease: Consistent with this, PGRMC1 protects from cell death induced by Aβ oligomer through inhibition of the mitochondrial apoptotic pathway.(56) Thus, PGRMC1 is a potential target for small molecule disease-modifying therapy for Alzheimer’s disease.